Integrating cytokines and angiogenic factors and tumour bulk with selected clinical criteria improves determination of prognosis in advanced renal cell carcinoma Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Renal Cell
  • Cytokines
  • E-Selectin
  • Kidney Neoplasms
  • Tissue Inhibitor of Metalloproteinase-1
  • Vascular Endothelial Growth Factor A

abstract

  • A prognostic model incorporating osteopontin, interleukin-6, TIMP-1, tumour burden, and selected clinical criteria increased prognostic accuracy for OS determination in mRCC patients.

publication date

  • August 8, 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5558688

Digital Object Identifier (DOI)

  • 10.1038/bjc.2017.206

PubMed ID

  • 28683470

Additional Document Info

start page

  • 478

end page

  • 484

volume

  • 117

number

  • 4